Today: 1 July 2026
Browse Category

Cryptocurrency 18 January 2026 - 20 January 2026

Bitcoin slides, but crypto presales say they’re raising millions — here’s what’s being pitched

Bitcoin slides, but crypto presales say they’re raising millions — here’s what’s being pitched

A wave of crypto presales is touting fresh capital inflows despite bitcoin’s recent drop, with paid promotions highlighting fundraising figures for tokens spanning “Bitcoin Layer 2” projects to meme coins. https://cryptodnes.bg/en/best-crypto-presales-why-bitcoin-hyper-and-maxi-doge-are-raising-millions/ Market sentiment has shifted to defensive territory. Bitcoin dropped below $92,000 amid tariff concerns rattling risk assets. Richard Galvin, co-founder of DACM, described the decline as “more a risk-off move than anything crypto-specific.” Over at BTC Markets, analyst Rachael Lucas noted traders have their eyes on $90,000 as the next key support level if the current floor gives way. https://www.businesstimes.com.sg/international/bitcoin-falls-below-us92000-tariff-fears-weigh-risk-assets
20 January 2026
Bitcoin price drops below $92,000 on Trump Greenland tariff threat as crypto selloff wipes $100 billion

Bitcoin price drops below $92,000 on Trump Greenland tariff threat as crypto selloff wipes $100 billion

Bitcoin tumbled up to 3.6% during Asian trading on Monday, dipping below $92,000 and dragging the broader crypto market down. Ether lost 4.9%, while Solana plunged 8.6%, according to Bloomberg. The selloff came after U.S. President Donald Trump threatened tariffs on eight European countries if the U.S. isn’t allowed to buy Greenland. The move sent investors fleeing to safer assets, pushing riskier bets aside. Berenberg’s chief economist Holger Schmieding said hopes that tariff tensions had eased “have been dashed for now,” as bitcoin dropped nearly 3% to $92,602.64.
20 January 2026
Visa card rollout, $4 million presale: Digitap’s $TAP gets pitched against XRP and Remittix

Visa card rollout, $4 million presale: Digitap’s $TAP gets pitched against XRP and Remittix

A press release on crypto site CryptoNinjas reported that the token presale for Digitap has exceeded $4 million. Promoters tout the project as a banking-style app featuring Visa cards. The post also drew a comparison between Digitap and DeepSnitch AI, another early-stage crypto venture leveraging artificial intelligence to analyze market data. The flurry matters because token presales—early-stage token sales typically held before a public exchange listing—have long provided a reliable funding stream for crypto projects, especially when venture capital dries up and retail traders lose interest.
Bitcoin price slips near $91,000 as ApeMars claims Stage 3 presale progress and Stacks STX ‘reversal’ talk builds

Bitcoin price slips near $91,000 as ApeMars claims Stage 3 presale progress and Stacks STX ‘reversal’ talk builds

ApeMars, a blockchain token project, said it has entered Stage 3 of its presale — an early token sale before wider exchange trading — with more than 4 billion tokens distributed, over 410 on-chain holders and about $84,000 raised. A sponsor-funded release carried by Markets Insider described bitcoin near the mid-$90,000s and solana in the mid-$100s, and said the 23-stage sale uses automatic price steps and token “burns” — removals from supply — with allocations recorded on-chain, or on the blockchain ledger. The disclosure said the publisher does not endorse or verify the information and warned that crypto investing can result in a total loss of capital. The market backdrop has shifted since that release hit. Bitcoin was down 1.8% at $91,266 on Tuesday, while ether fell 3.5% to $3,099 and solana dropped 3.6% to $128.84, CoinMarketCap data showed. Stacks’ STX token was down 3.8% at about $0.315, and cronos slid 2.2% to about $0.0917.
20 January 2026
Bitcoin drops toward $92,000-$93,000, wiping out $790 million longs as traders eye $80K

Bitcoin drops toward $92,000-$93,000, wiping out $790 million longs as traders eye $80K

Bitcoin’s slide toward $93,000 sparked a massive purge of leveraged bullish bets, wiping out roughly $874 million in crypto positions in the last 24 hours, according to CoinGlass data reported by NewsBTC. Long positions — wagers on a price increase — made up about $788 million of that total. The move is grabbing attention as traders treat tariff news like a fresh macro shock after weeks of sideways action. U.S. cash markets are set to reopen Tuesday following Monday’s holiday. Some chart watchers are openly calling this a potential “liquidity grab”—trader jargon for a quick price move targeting stop orders—near the 2026 open at about $87,000 and the range floor around $80,500. “Bitcoin and Gold trendlines are literally on top of each other,” said network economist Timothy Peterson, suggesting the two could still align after following different paths.
20 January 2026
White House says seized Samourai Bitcoin won’t be sold — and the U.S. reserve plan is still stuck in legal knots

White House says seized Samourai Bitcoin won’t be sold — and the U.S. reserve plan is still stuck in legal knots

A senior White House crypto advisor confirmed the U.S. Justice Department has not sold the bitcoin seized in the Samourai Wallet case. Instead, it will stay in the government’s Strategic Bitcoin Reserve. https://www.theblock.co/post/386022/bitcoin-forfeited-as-part-of-samourai-case-was-not-sold-and-will-stay-in-the-strategic-reserve-says-top-white-house-crypto-advisor This clarification is crucial for traders since the volume of bitcoin held by the U.S. is significant enough to shake prices, even if sold in small amounts. The Samourai transfer was closely monitored to see if the administration’s “do not sell” stance would hold once seized coins start shifting between agencies and custodians.
20 January 2026
Wall Street is shut for MLK Day — the 2026 U.S. market holiday calendar and the crypto ETF catch

Wall Street is shut for MLK Day — the 2026 U.S. market holiday calendar and the crypto ETF catch

U.S. stock markets, including the New York Stock Exchange and Nasdaq, will be closed Monday in observance of Martin Luther King Jr. Day. Trading picks back up Tuesday. The next full-market closure won’t be until Presidents Day on Feb. 16, 2026. The timing is crucial since the U.S. operates on a T+1 settlement cycle—meaning trades settle one business day after the trade date—for most stocks and ETFs. With Monday a holiday, trades executed late last week won’t settle until Tuesday, delaying the cash and share exchange by a full day.
Bitcoin whale sells $48 million after 12 years — and the market isn’t panicking

Bitcoin whale sells $48 million after 12 years — and the market isn’t panicking

A Bitcoin “whale” — a term for a major holder — offloaded another 500 bitcoins, valued at about $47.77 million, sending them to Binance, on-chain analyst EmberCN reported. The same address began accumulating back in November 2013, building a 5,000-BTC stash. Since November 2024, it has transferred around 2,500 BTC to Binance, netting approximately $260 million in gains, the analyst added. Bitcoin’s price hovered near $92,531 during London morning trading, where it remains vulnerable to leverage-fueled swings. The recent drop came after new tariff threats, wiping out roughly $790 million in bullish bets within 24 hours, according to CoinGlass data cited by Business Standard. Rachael Lucas, an analyst at BTC Markets, said traders are eyeing $90,000 as the next level if current support gives way. Richard Galvin, co-founder of hedge fund DACM, called the selloff “more a risk-off move than anything crypto-specific.”
19 January 2026
1 35 36 37 38 39 106

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Go toTop